Samantha McLemore - Patient Capital Management,
Holding/activity history for Dxc Technology Co (DXC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 1.47 | SEC | ||
| 2023 Q3 | 1,198,173 | 1.47 | Add 1,064.97% | 1.34 | $20.83 | $24,957,935 | SEC |
| 2023 Q2 | 102,850 | 0.15 | Add 71.42% | 0.06 | $26.72 | $2,748,152 | SEC |
| 2023 Q1 | 60,000 | 0.69 | Reduce 62.64% | 1.32 | $25.56 | $1,533,600 | SEC |
| 2022 Q4 | 160,600 | 2.10 | Reduce 15.47% | 0.37 | $26.50 | $4,255,900 | SEC |
| 2022 Q3 | 190,000 | 2.36 | Reduce 30.04% | 1.21 | $24.48 | $4,651,000 | SEC |
| 2022 Q2 | 271,600 | 4.04 | Reduce 9.95% | 0.39 | $30.31 | $8,232,000 | SEC |
| 2022 Q1 | 301,600 | 3.88 | Reduce 6.83% | 0.29 | $32.63 | $9,841,000 | SEC |
| 2021 Q4 | 323,700 | 4.22 | $32.19 | $10,420,000 | SEC |